Sysmex Europe Launches Automated Blood Testing Platform for Alzheimer’s Disease
The system uses routine blood draws to provide results in 17 minutes, offering an alternative to invasive diagnostic methods.
Read More
Search Results for: parkinson
Can an Alzheimer’s Blood Test Detect Early, Subtle Cognitive Decline?
Biomarkers in midlife adults without dementia may be linked to the earliest signs of waning cognition, researchers found.
Read More
Researchers Develop Blood Test Sensor for Early Alzheimer’s and Parkinson’s Detection
The sensor identifies misfolded protein biomarkers in blood before clinical symptoms of neurodegeneration appear.
Read More
Researchers Develop Test to Detect Biomarkers for Specific Type of Dementia
Researchers at Mass General Brigham have developed a digital seed amplification assay that detects TDP-43 protein seeds in cerebrospinal fluid, enabling identification of FTLD-TDP, a specific frontotemporal lobar degeneration subtype.
Read More
NeuroVision Acquires Durin Life Sciences for Neurodegenerative Disease Diagnostics
NeuroVision Imaging has acquired Durin Life Sciences, combining blood-based biomarker tests with retinal imaging and telehealth to advance early detection of Alzheimer’s and Parkinson’s diseases.
Read More